Headline profit masks the organic quarter; execution intact, but transition pain persists
Ugro's reported PAT jumped 98.9%, but interest income fell 13% quarter-on-quarter, and AUM remained flat despite near-60% disbursement growth. Management reaffirmed its FY29 targets; the market fled anyway—and the data shows why.
₹67.9 Cr
+98.9% YoY
2.8% vs 2.1%
Tax reversal benefit ~70 bps
₹496.9 Cr
+20% YoY
-13%
Despite +19% YoY; reversal embedded
Ugro's Q1 result table showed a blowout: PAT nearly doubled, revenue grew 20%, and cost cuts were completed ahead of schedule. But peel back the headline and the quarter reads differently. Interest income fell 13% quarter-on-quarter despite rising 19% year-on-year—a gap that signals embedded income reversals from the Prime portfolio runoff. AUM was entirely flat despite near-60% net disbursement growth, meaning the runoff (25% annualized, faster than the 20% guided) is happening faster than management publicly signaled. Reported PAT includes a one-time tax reversal from the migration to the new tax regime; normalized (underlying) ROA is 2.1%, not the 2.8% the reported number implies. And the market has already priced this tension: the stock sold off day 1 post-result and never recovered, with foreign institutional investors fleeing (holdings crashed from 22.33% to 5.45% in a single quarter). The quarter confirms management's operational execution—but also confirms what skeptics feared: the transition is real, painful, and will take multi-quarter proof to convince the street.
The PAT story: reported vs. underlying
Reported PAT of ₹67.9 Cr is a 98.9% YoY jump, but this number embeds a one-time gain from the company's migration to the new tax regime. When you back out that benefit, the underlying ROA (and the profit it represents) is 2.1%—not the 2.8% reported. That is a vastly different picture than the headline number suggests and is the true foundation from which management is claiming a path to 3.0–3.5% ROA by FY29. The year-on-year growth story (PAT +98.9%, revenue +20%) is real, but the organic quarter is softer: interest income QoQ down 13%, which is the main red flag embedded in a good-looking revenue story.
Interest income and the earnings quality flag
Interest income up 19% YoY driven by portfolio yield mix improvement
₹363 Cr up 19% YoY; portfolio yield 18.1% (+63 bps QoQ) via EM LAP/GROx mix shift
Supported
Opex cut substantially complete, running at ~₹490 Cr annual rate
Q1 opex ₹119 Cr (₹476 Cr annualized); down 42% QoQ from ₹217 Cr Q4. Matches ₹220 Cr reduction plan
Supported
Emerging Market LAP growing 9% QoQ with mature branches at ₹81 Lakh/month productivity
AUM ₹3,896 Cr (+9% QoQ), 317 branches. Mature cohort (>12 months) at ₹81 Lakh/month (target ₹80–85)
Supported
Interest income will grow quarter-on-quarter from Q1 base
Interest income ₹363 Cr down 13% QoQ (embedded ₹30+ Cr reversal from DSA foreclosure). Inflection timing vague
Partially answered
AUM flat (flattish transition as guided)
AUM ₹15,013 Cr flat YoY; runoff 25% vs. 20% guided. Disbursement growth 59% YoY not translating to AUM growth
Confirmed but worse than implied
The interest income story is the earnings quality flag. Yes, ₹363 Cr is up 19% year-on-year. But it fell 13% quarter-on-quarter—a reversal that confounds a good headline. The culprit: the Prime intermediated portfolio (DSA-led) is running off at 25% annualized, faster than the 20% management guided for. That runoff embeds income reversals—off-balance sheet contracts that recognized income upfront now reverse as loans foreclose. Management quantified it as ₹30+ Cr embedded in the Q1 income statement. On-balance sheet interest earning assets are growing (the higher-yielding EM LAP and GROx pools), but they're not yet large enough to overcome the DSA foreclosure tail. Portfolio yield improved 63 basis points to 18.1%, which is healthy; but the absolute quantum of interest income QoQ still fell. This is the structural transition pain: you're shifting from a low-yield, capital-light intermediation model to a higher-yield, capital-intensive direct origination model, and there's a valley in the middle.
The co-lend/direct assignment (DA) income bucket tells the same story: ₹75 Cr in Q1 vs. ₹155 Cr in Q4, a 52% QoQ decline. This is intentional runoff—management is explicitly de-risking the capital-light tail—but it also embeds further income reversals. Co-lend declined from 24% of total income to 14%, and management is guiding it to stabilize at this 14% run rate through FY27, then decline to 4% by end-FY28. If that plan holds, by end-FY29 the portfolio will be nearly 85% direct origination (EM LAP and GROx), with profitability driven by cash interest, not capital reversals. But in the near term (FY27–FY28), this transition creates earnings volatility that the headline numbers don't capture.
What changed on this call
EM LAP and GROx beating 25% CAGR targets (9% QoQ and 32% QoQ vs. guidance)
Prime runoff accelerating: 25% annualized vs. 20% guided (shortens transition but increases near-term volatility)
Opex reduction fully delivered; Q1 annualized rate ₹476 Cr vs. ₹490 Cr guidance
Co-lend income stabilizing at 14% run rate for FY27 (as guided; decline to 4% by Q4 FY28 on track)
July 2026 milestone: ₹1,000 Cr monthly disbursement achieved (validates dual-engine scaling thesis)
FY29 targets reaffirmed (25% CAGR, 85% AUM mix, 3.0–3.5% ROA). Intermediate guidance (FY27–28) remains vague
The most material shift is acceleration of Prime runoff: 25% annualized vs. the 20% management guided. This is happening faster than publicly signaled, which compresses the transition timeline but also increases the risk of extended flatness or near-term AUM volatility. The growth engines (EM LAP and GROx) are outpacing targets, which is credible and good. But the faster runoff means the net of those two forces is still zero—AUM flat despite 59% net disbursement growth. Management's rationale is that faster foreclosure of the DSA portfolio is intentional (collection infrastructure, avoiding negative carry, income reversal risk)—but it also signals that the customer base in that segment is stressing faster than implied. This is a data point to watch for early warning on credit quality elsewhere.
How the street is positioned (and what it's telling you)
Post-result price action: The stock fell 1.36% on day 1 post-announcement, 2.15% by day 3, and 1.12% by day 5. The sell-off held; there was no recovery. This is the market's own verdict on the print: good headline numbers, but not convinced on intermediate execution. The stock is now down 50.85% from its all-time high of ₹189.92, trading below all moving averages (SMA20 ₹95.3, SMA50 ₹96.16, SMA200 ₹125.73). RSI is neutral at 42.1, suggesting the stock isn't yet oversold—a warning that further downside may be possible if the company misses on intermediate guidance.
Foreign institutional exodus: The most damning signal is the FII collapse. Institutional ownership crashed from 22.33% (Q4 FY26) to 5.45% (Q1 FY27)—a 16.88 percentage-point drop in a single quarter, coinciding with the result announcement. This isn't gradual profit-taking; it's a rout. Institutions exited just as the company reaffirmed its FY29 guidance. The message is unambiguous: the street doesn't believe the intermediate thesis and doesn't want to hold through the transition pain. DII ownership barely budged (1.68% → 1.85%), meaning domestic institutions aren't stepping in either. At ₹93.34, the stock isn't attracting buyers at any institutional tier.
Valuation and opportunity cost: The stock is trading at roughly 0.5x book value, by management's own acknowledgement during the Q&A. This reflects investor skepticism on three fronts: (1) the ROA inflection from 2.1% to 3.5% is unproven at scale and multi-quarter; (2) intermediate guidance is absent, leaving investors to extrapolate; (3) FII exodus signals macro/sentiment headwinds (management blamed PE fund exits, Iran war timing on F&B merchants, and mutual fund market-cap entry biases—all valid, but institutional money doesn't wait for macro clarity). For a holder, this means the path to 0.7x or 1.0x book is contingent on Q2–Q3 delivering visibility on AUM inflection and normalized ROA trending toward 2.5%+.
The bull-bear ledger
Growth engines (EM LAP, GROx) beating 25% CAGR targets; 9% and 32% QoQ growth is strong
Opex cut fully delivered (₹220 Cr reduction, Q1 at annualized run rate); cost-base reset complete
GNPA stable at 2.1–2.6% across engines; within modeled peak expectations. Early warning systems (post-Iran war daily monitoring) in place
Portfolio yield improved 63 bps to 18.1% via mix shift; higher-yielding segments (EM LAP 18.5%, GROx 26%) now 46% of AUM
July 2026: ₹1,000 Cr/month disbursement milestone validates dual-engine capacity and self-funding thesis
Reported PAT inflated by one-time tax reversal; normalized profit basis only 2.1% ROA, not 2.8%
AUM flat despite 59% disbursement growth; runoff at 25% vs. 20% guided accelerating transition but masking underlying growth
Interest income down 13% QoQ despite 20% YoY revenue growth; ₹30+ Cr embedded reversals from DSA foreclosure clouding organic momentum
Intermediate guidance sparse (FY27–28 absent); only FY29 targets articulated. Management vague on interest income inflection timing
FII fled 16.88pp in a single quarter during result announcement; institutions aren't convinced by the pitch
Execution risks explicitly named (branch productivity ramp, GROx credit expansion, runoff acceleration) but mitigation conditional on 'if things go as expected'
Risks, ranked by severity for a holder
Credit quality deterioration: EM LAP GNPA 2.1% and GROx 2.1% (peaks expected 3.5–4% and <3% respectively at 18-month seasoning)
HighIf both breach peak expectations, credit cost could exceed 1.5–2% guidance, compressing margins by 50–100 bps and delaying ROA inflection. GNPA breaches would also force regulatory provisioning, tightening capital.
Prime portfolio runoff acceleration: Running at 25% vs. 20% guided; if >30%, income reversal pressure could offset operational improvements
HighFaster runoff = more embedded reversals, lower reported profit in FY27–28. Combined with slower on-balance sheet growth, this extends AUM flatness and delays the inflection management is promising.
AUM inflection failure: Currently flat despite 59% disbursement growth. If runoff doesn't moderate or disbursement growth doesn't sustain, AUM could stay flat or decline through FY27
HighAUM is the denominator for ROA expansion. If AUM flatness extends beyond H2 FY27, the 3.5% ROA target by FY29 becomes mathematically harder to achieve.
Interest income structural floor: QoQ decline (-13%) from DSA runoff and lack of on-balance sheet asset growth. If inflection doesn't occur in Q2–Q3, management's 'Q1 is the base' narrative loses credibility
MediumInterest income is the largest revenue bucket (73% of total). Structural decline undermines the case for absolute profit growth, even if margins expand.
Branch productivity ramp failure: 145 EM LAP branches <6 months old must scale to ₹75–80 Lakh/month by 12-month mark. If productivity stays at ₹30–40 Lakh/month longer, AUM growth gets delayed
MediumThis is the execution lever that determines whether disbursement growth translates to AUM growth. Miss this, and transition extends into FY28.
GROx credit expansion risk: Platform expanding into longer-tenure (18–24 months), higher-ticket marketplace loans. Unproven credit quality at scale and longer duration
MediumCurrent GROx model relies on velocity and short tenure (12–13 months). Expanding into longer assets increases credit risk exposure and duration mismatch if funding is short-term.
The debate
1 · Interest income trajectory (Q2 FY27)
Did it stabilize or reverse again? Management claimed 'Q1 is the base, interest income will grow QoQ from here.' Q2 data will confirm or contradict. If interest income is down again QoQ in Q2, the credibility of management's near-term guidance will be in question.
2 · AUM growth inflection (Q2–Q3 FY27)
Will AUM finally turn positive, or does it stay flat? Currently flat ₹15,013 Cr despite 59% disbursement growth (runoff at 25% vs. 20% guided). If AUM remains flat into Q3, the transition timeline extends into FY28, and FY29 targets face credibility loss.
3 · Credit quality (EM LAP, GROx GNPA, Q2–Q3)
Are we tracking within modeled peaks (EM LAP 3.5–4%, GROx <3% at full seasoning)? If GNPA breaches expectations by Q3, credit costs will exceed 1.5–2% guidance and compress the ROA pathway. Early warning: post-Iran war spike in F&B merchant defaults is being monitored daily.
4 · FII positioning and institutional confidence
Will FII stabilize or continue exiting? Ownership at 5.45% is near historical low. If DII or FII starts accumulating in Q2–Q3, it signals street is coming back to the story. If ownership stays flat/declines, it confirms institutions aren't convinced by current guidance.
Ugro's Q1 result is a quarter of operational execution masked by transition pain. The company hit its targets on cost, growth engines, and credit quality. But the underlying business is showing stress: flat AUM despite 60% disbursement growth, QoQ interest income decline despite YoY growth, and normalized profit lower than reported. Management's reaffirmation of FY29 targets without intermediate guidance is a credibility wager, not a certainty. The market's harsh verdict (FII exodus, 50% drawdown, persistent sell-off) isn't macro noise; it's the street correctly pricing execution risk and demanding proof before re-rating valuation.
The honest read: This is a Hold. The execution on stated priorities (growth, cost, credit) is credible, but the quarter proves that the transition will take multiple quarters to resolve. The stock at ₹93.34 (0.5x book) isn't cheap; it's fairly valued for an unproven inflection story. If Q2–Q3 show AUM inflection and interest income stabilizing, the re-rating from 0.5x book to 0.7–1.0x would be justified. Until then, there's no edge in being early.
The single number to track: normalized ROA (not reported ROA). The reported figure is inflated by a one-time tax reversal; the true metric is the 2.1% base. Watch for it to trend toward 2.5%+ by Q4 FY27. If normalized ROA is still <2.3% by Q3 FY27, the FY29 3.5% target loses credibility, and the stock likely re-rates lower.
Execution intact, transition headwinds persist; multi-year view intact
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Met Q1 revenue (+20%) and beat PAT (+98.9% YoY). Core business metrics (EM LAP, GROx, GNPA, opex) aligned with prior guidance. Reaffirmed FY29 targets (25% CAGR, 85% AUM, 3-3.5% ROA) and confirmed no incremental equity needed. Caveat: intermediate-term (FY27–FY28) guidance vague; interest income inflection timing not crisply articulated.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Ugro is executing its strategic pivot credibly—both Emerging Market LAP and Embedded Finance beat guidance (growing faster than 25% CAGR targets), cost reduction completed (₹220 Cr delivered), and GNPA stable at 2.1-2.6%. But the quarter revealed structural transition pain: interest income down 13% QoQ despite revenue up 20% YoY, AUM flat (the 'flattish' FY27 transition is real), and ROE weak at 9.2%. Management's thesis (sustainable 3.0-3.5% ROA by FY29, self-funded growth, no dilution) is credible but unproven at scale; it requires 3–4 consecutive quarters of execution with credit discipline as GROx expands into higher-ticket, longer-tenure assets. Share price at 0.5x book reflects investor skepticism on transition risk and ROA inflection. Hold pending visibility on ROA and AUM trajectory improvement in Q2–Q3.
₹496.9 Cr
Revenue · +20% YoY₹67.9 Cr
Reported PAT · +98.9% YoYExpanding
Margins · vs guidance: CorroboratedDid the claims hold up?
Interest income up 19% YoY driven by portfolio yield mix improvement
METInterest income ₹363 Cr up 19% YoY; portfolio yield 18.1% up 63 bps QoQ from high-yield EM/GROx mix shift
Opex cut substantially complete, running at ~₹490 Cr annual rate
METQ1 opex ₹119 Cr (₹476 Cr annualized); down 42% QoQ from Q4 ₹217 Cr, down 2% YoY. Matches stated ~₹220 Cr reduction plan
Emerging Market LAP growing 9% QoQ with 317 branches, mature cohort at ₹81 Lakh monthly productivity
METAUM ₹3,581 Cr (Mar) to ₹3,896 Cr (Jun), 9% QoQ growth. Branches >12 months: ₹81 Lakh/month (target ₹80-85 Lakh). Within expectations
GROx scaling at 32% QoQ, 4x in 5 quarters, 60k loans/month with 26% yield
METGROx AUM ₹2,280 Cr to ₹3,003 Cr (32% QoQ). Disbursements ₹1,853 Cr, 60k+ loans/month, 3.4 Lakh active customers, 26% yield, 2.1% GNPA
Co-lend/DA income planned decline to 14% of total by Q1 from 24% in Q4
METCo-lend/DA ₹75 Cr (14% of ₹535 Cr total income) vs ₹155 Cr in Q4 (24% of Q4 income). Exactly as guided
GNPA stable at 2.1-2.6% range across both engines vs peak delinquency models of 3.5%-4%
METEM LAP GNPA 2.1%, Embedded Finance 2.1%, overall AUM GNPA 2.6%. Management reiterated peaks projected at 3%-3.5% for EM, <3% for Embedded based on seasoning
Earnings quality
What changed since the last call
FY27 operating cost target reaffirmed at ₹490 Cr
MaintainedQ1 opex ₹119 Cr (₹476 Cr annualized run rate) vs ₹217 Cr Q4. Stated 'approximately ₹220 Cr annualized reduction' delivered; all action complete. Opex expected flat rest of FY27.
Co-lend/DA decline trajectory held: 24% of income (Q4) → 14% (Q1) → 4% target
Maintained₹155 Cr (Q4) → ₹75 Cr (Q1), 52% decline. Management confirmed this is the run rate for FY27; end of 12-quarter journey to 4% by Q4 FY28 matches prior guidance.
EM LAP and GROx now 46% of AUM (vs 32% Dec '25), both beating 25% CAGR targets
UpgradeEM LAP growing faster than 25% (9% QoQ = ~40% annualized), GROx 32% QoQ (>25%). On pace to exceed 85% of AUM by FY29 target. Execution momentum strengthening.
Prime portfolio rundown accelerating: 20% annual guidance, actual 25% runoff
DowngradePortfolio exiting faster than planned; foreclosures of DSA book higher. Creates income reversal headwind short-term but accelerates transition. Management candid: 'simultaneously accelerating intended transition.'
July 2026 milestone: first-ever ₹1,000 Cr monthly disbursement (June was lower)
UpgradeCombined EM + GROx capacity at ₹1,000 Cr/month (July standalone, not embedded in Q1 numbers). Validates dual-engine scaling thesis; new capacity floor.
The Q&A
Analysts pressed hard on three themes: (1) QoQ interest income decline (Neel Advani: when does it stabilize?), management held line that Q1 is 'the base,' will grow QoQ from here as on-balance sheet grows; (2) Valuation and DSA portfolio exit (Rishi: why not sell the whole business, why hold till FY29?), management defended portfolio run-off vs sale (collection infrastructure, negative carry, income reversal risk) but acknowledged investor frustration—defensive but consistent. (3) Execution risks (Kamal, Ritesh), management named three concrete risks (branch productivity ramp, GROx credit risk expansion, runoff acceleration) without deflection. Q&A tone: confident but not dismissive of concerns.
AUM and ROE guidance — Amit Mehendale, Robo Capital
PartialFY27 AUM flat; on-balance sheet assets growing. FY29 guidance: EM 25% CAGR, GROx 25% CAGR, Prime -20% rundown (actual -25%). Overall ~15% AUM growth FY27–FY29. ROE now 9.2%; path to higher levels via ROA expansion.
Sequential interest income decline — Neel Advani, Pico Capital
AnsweredQ1 is the base. Opex now flat. Interest income will grow QoQ from here as on-balance sheet assets grow. Co-lend at ₹75 Cr is run rate for FY27 (function of foreclosure pace). ROA normalized at 2.1%, pathway to 3–3.5% via leverage.
Portfolio GNPA trajectory — Neel Advani, Pico Capital
AnsweredProjection well within expectations. EM LAP peak delinquencies 3.5%–4% when avg tenure 18 months (currently 15 months). Embedded Finance expected <3% (vs higher prior projection). Credit cost EM LAP 1.5%–2% guidance held.
DSA portfolio exit strategy — Rishi, individual investor
AnsweredSale requires 6-month vintage (not all DSA has it). Piecemeal sale uneconomical (collection infrastructure fixed). On-balance sheet and off-balance sheet mix; full sale triggers large income reversal. Expects market to understand runoff narrative in 1–2 more quarters.
Shareholder voting and valuation — Rishi, individual investor
PartialProfectus at 1.1x book, generates more cash than goodwill paid. Acquisition was sound. Current valuation driven by PE fund exits (50% held by 4–5 PE investors), Iran war timing, and mutual fund market-cap bias for IPO entry. Expects reset when growth trajectory becomes established.
Execution risks and GNPA management — Ritesh Khandelwal, retail investor
PartialCredit risk (both engines small-ticket customers, early warning signals post-Middle East war, daily monitoring via GROx). Cost of borrowing (improving but not yet factored into FY29 projections). Not explicitly detailed third.
Execution risks: self-funding assumptions — Kamal, individual investor
AnsweredThree execution risks: (1) EM branch <6-month cohort (145 branches) must scale to ₹75–80 Lakh/month by 12-month mark. (2) GROx expansion into longer-tenure, higher-ticket assets (marketplaces) risks credit deterioration. (3) Runoff presumed 20% but actual 25%; if too fast, income reversal pressure. All being monitored; July showed branch targets achievable.
Guidance
Interest income to grow QoQ from Q1 base as on-balance sheet assets increase
MediumContingent on opex staying flat (delivered in Q1) and co-lend/DA stabilizing at ₹75 Cr run rate. Depends on AUM inflection beginning in H2 FY27.
EM LAP and GROx each targeting 25% CAGR through FY29; both currently beating target
HighEM LAP growing faster than 25% (9% QoQ), GROx 32% QoQ. Track record of exceeding guidance. Assumes credit discipline holds as GROx expands into longer-tenure assets.
Prime intermediated portfolio to run down ~20% annually (actual 25% in Q1 transition)
HighRunning faster than guided (25% vs 20%), accelerating transition. Intensity may moderate as portfolio base shrinks in H2.
Achieve 3.0–3.5% sustainable ROA by FY29 from normalized 2.1% Q1 base
MediumAssumes 3 drivers hold: (1) opex stays flat (not declining further), (2) interest income grows with AUM, (3) co-lend/DA remains at 14% of total income declining to 4%. Post-tax ROE today 9.2%; path to 15%+ requires ROA inflection.
Portfolio yield to remain in 18%+ range as EM LAP and GROx dominate AUM
HighEM LAP at 18.5%, GROx at 26%. Blended yield of 46% of AUM mix is strong. Assumes Prime rundown (lower yield) continues at >20% annually.
No incremental equity raises through FY29; self-funded growth via internal accruals
MediumAssumes no major stress on capital adequacy (now 21% standalone, ~23–24% on merged basis post-NCLT). Contingent on GNPA staying below 3.5% peak, profitability sustaining, and AUM growth within leverage tolerance.
Risks the call surfaced
Credit quality deterioration
HighEM LAP GNPA at 2.1% (peak expected 3.5%–4% at 18-month seasoning; currently 15 months). GROx GNPA 2.1% (peak expected <3%). If both breach peaks, credit cost could exceed 1.5–2% guidance, compressing margins by 50–100 bps.
Portfolio runoff acceleration
HighPrime rundown at 25% annualized vs 20% guided. Runoff embeds income reversals (off-balance sheet co-lend/DA contracts running off faster than amortization schedule). If acceleration continues >30%, reversal impacts could pressure reported profitability despite operational improvements.
Interest income cliff / revenue volatility
MediumInterest income ₹363 Cr down 13% QoQ despite 20% YoY growth. On-book interest earned only on on-balance sheet portfolio; off-balance sheet DSA foreclosure upfront DSA cost recognition creates income reversal bucket. If on-balance sheet asset growth doesn't accelerate, interest income could remain suppressed through FY27.
Execution risk: branch productivity ramp
Medium145 branches less than 6 months old must scale to ₹75–80 Lakh/month by 12-month mark to offset Prime rundown. If branch productivity lags (stays at ₹30–40 Lakh range longer), EM LAP AUM growth may not offset rundown, extending AUM flatness beyond FY27.
Funding cost risk
LowCost of borrowing improved 41 bps YoY to 10.14% (7th consecutive quarterly improvement). Management hopes continued decline as AUM scales, but has NOT baked into FY29 projections. If AUM growth stalls, funding cost may plateau or rise, capping ROA upside.
Management
Score 7/10. Clear articulation of strategy and operational metrics. Transparent on transition pain (interest income QoQ decline, AUM flatness, income reversals). Candid on risks (branch productivity, GROx credit expansion, runoff). Defensive on valuation but not dismissive. Avoids near-term (FY27–28) specificity; leans on FY29 medium-term targets. Strong track record: beat EM LAP and GROx growth targets (25% CAGR guidance, actual 9% and 32% QoQ). Opex cut delivered ahead of schedule (₹220 Cr, Q1 at annualized run rate). Revenue +20% YoY as guided. PAT beat expectations (+98.9%). GNPA and credit cost guided and delivered. Caveat: AUM flatness and interest income QoQ decline not clearly forecast.
1 · Q2 FY27
Interest income inflection from growing on-balance sheet assets
2 · Q2–Q3 FY27
Emerging Market LAP 96 mature branches scale to ₹80–85 Lakh/month, offset <6-month cohort ramp
3 · Q3 FY27
GROx platform expansion into commerce/marketplace partnerships (longer-tenure loans)
Hold pending visibility on ROA and AUM trajectory improvement in Q2–Q3.
UGRO Capital Q1FY27: consolidated PAT ₹67.87 Cr, but underlying PBT growth near-flat
PAT +98.85% YoY · revenue +20.04% · margins flat
₹496.94 Cr
+20.04% YoY
₹67.87 Cr
+98.85% YoY
12.69%
+4.6pp YoY
₹4.44
UGRO Capital's consolidated Q1FY27 (quarter ended June 30, 2026) print headlines well — revenue from operations of ₹496.94 Cr and PAT of ₹67.87 Cr, up 32.8% QoQ and a nominal 98.8% YoY against the ₹34.13 Cr standalone base reported a year ago, before the Profectus Capital and Grox Technologies acquisitions were consolidated. On a like-for-like standalone (parent-only) basis, PAT was ₹60.71 Cr on revenue of ₹417.41 Cr, up just 0.82% YoY at the revenue line. Consolidated basic EPS was ₹4.44 versus ₹3.35 in Q4FY26; standalone basic EPS was ₹3.97 versus ₹1.94 in Q4FY26 and ₹3.61 a year ago. No management press release has been extracted for this filing, so there is no company framing to cross-check against the numbers beyond the regulatory filing itself.
Q1 FY-2027 vs prior quarters
The reported profit jump is not an operating story. Standalone pre-tax profit (PBT) was ₹48.66 Cr, up just 1.02% YoY from ₹48.17 Cr — essentially flat — and consolidated PBT of ₹61.54 Cr was actually down 13.6% QoQ from ₹71.24 Cr in Q4FY26. What moved PAT was the tax line: the company opted into the concessional tax regime under the new Income-tax Act, 2025 (Section 200), cutting its corporate rate from 29.12% to 25.17% (note 11), and the resulting deferred-tax remeasurement flipped standalone tax expense to a ₹12.05 Cr credit (versus a ₹14.04 Cr charge a year ago) and consolidated tax to a ₹6.33 Cr credit. Strip this one-off out and use PBT as the organic yardstick, and adjusted YoY PAT growth is roughly +1%, not the +98.8% headline. Standalone net profit margin of 13.37% (Q4: 5.80%, year-ago: 8.09%) reflects this tax swing rather than operating margin expansion.
The stock went into the print at ₹97.48, down 0.5% over the past month of trading.
For context: this is the highest quarterly PAT in the last 6 quarters on our records; PAT has now risen for 2 consecutive quarters.
Management guides for a transitional FY27 with flattish AUM as the prime, intermediated portfolio is run down by 15-20% annually. The strategic focus is on aggressively growing the higher-yielding Emerging Market LAP and Embedded Finance verticals to constitute 85% of AUM by FY29. The company is committed to no increme
— This quarter: met
Consolidated revenue fell 18.1% QoQ to ₹496.94 Cr from ₹606.57 Cr, driven mainly by a drop in net gain on derecognition of financial instruments (loan assignment/securitisation income) to ₹74.87 Cr from ₹154.59 Cr in Q4FY26 — a deal-timing-dependent line for an NBFC that actively co-lends and assigns loans. No quarter-specific Street consensus could be confirmed for this print; general pre-result commentary pointed to ~15-20% full-year FY27 PAT growth expectations, but no single-quarter estimate was found, so vsStreet is marked unknown. Against management's prior guidance — a transitional FY27 with flattish AUM as the prime intermediated book is run down 15-20% annually while Emerging Market LAP and Embedded Finance are scaled, no incremental equity raises through FY29, and a target cash-led ROA of 3.0-3.5% by FY29 — this quarter's roughly flat organic revenue and profit fits the 'transitional, flattish' framing directionally, though this filing carries no AUM breakdown, so the LAP/Embedded-Finance mix shift and ROA trajectory specifically could not be verified from the P&L alone.
W1
NCLT pronouncement on the Profectus-UGRO amalgamation scheme (reserved after the July 24, 2026 hearing) and its accounting impact on consolidated results.
W2
Whether the post-quarter record ₹1,000 Cr monthly disbursement (announced Aug 3, 2026) sustains into Q2FY27, given Q1's sharp fall in assignment/derecognition income.
W3
Effective tax rate normalization: this quarter's credit was a one-off from the regime switch — watch whether Q2FY27 tax reverts toward a ~25-29% effective rate, pulling reported PAT growth back to the underlying ~1% PBT trend.